Japan`s Otsuka to buy drugmaker Avanir for $3.5 bn
The acquisition is a push by Otsuka to accelerate its expansion in treating diseases that affect the central nervous system, the Japanese firm said.
Dec 02, 2014, 17:55 PM IST
The acquisition is a push by Otsuka to accelerate its expansion in treating diseases that affect the central nervous system, the Japanese firm said.
Dec 02, 2014, 17:55 PM IST